Search documents
HarrisX and 2WAY Launch "Capital Intel," a First-of-its-Kind Interactive Polling Program
Accessnewswire· 2026-03-30 16:45
HarrisX and 2WAY Launch "Capital Intel," a First-of-its-Kind Interactive Polling Program "Polling is key to allowing audiences to understand the nuances within our contemporary politics, yet it remains largely inaccessible, mistrusted, or misunderstood by everyday audiences," said Mark Penn, Chairman and CEO of Stagwell. "What 'Capital Intel' introduces is a new model-combining sophisticated, high-frequency polling data with a modern, interactive format, making these insi ...
中国神华(01088)公布2025年业绩 归母净利润约542.18亿元 同比减少8.9% 末期息每股1.03元
智通财经网· 2026-03-30 16:44
智通财经APP讯,中国神华(01088)公布2025年业绩,收入为2949.16亿元,同比减少13.2%;归属于公司 所有者的本年利润约542.18亿元,同比减少8.9%;基本每股盈利2.729元,末期股息现金1.03元 ╱ 股。 公告称,收入下降主要原因是:① 受煤炭市场供求关係等因素影响,集团煤炭销售量及平均销售价格 分别下降6.4%和12.1%,导致煤炭销售收入同比下降; ② 受煤电利用小时下降、电价下行等因素影响, 集团售电量及平均售电价格分别下降3.9%和4.0%,导致售电收入同比下降。 ...
Boston Scientific Drops Despite Encouraging Trial Readouts
Benzinga· 2026-03-30 16:44
WATCHMAN FLX Shows Bleeding Advantage, Matches EfficacyThe CHAMPION-AF study results shared on Saturday highlighted the WATCHMAN FLX device’s efficacy compared to traditional blood thinners as a first-line option for stroke risk reduction in a broad population of patients with non-valvular atrial fibrillation (NVAF), a common heart rhythm disorder.The CHAMPION-AF trial demonstrated that the WATCHMAN FLX device provided statistically superior protection from bleeding while showing similar efficacy to non-vit ...
ProPetro awarded ‘Buy’ rating in initial coverage from Bank of America
Yahoo Finance· 2026-03-30 16:44
ProPetro awarded ‘Buy’ rating in initial coverage from Bank of America Proactive uses images sourced from Shutterstock Bank of America has initiated coverage on ProPetro (NYSE:PUMP) with a 'Buy' rating and a price objective of $18, citing a combination of cyclical recovery in oilfield services and longer-term growth in power infrastructure. Shares of ProPetro traded up almost 3% at $15 on Monday afternoon. The bank’s analysts believe ProPetro is well placed for a recovery in hydraulic fracturing, or “ ...
马斯克:特斯拉(TSLA.O)正在日本进行大规模投资,包括服务设施和超级充电站的建设。特斯拉的许多零部件都是在日本制造的。在过去的20年里,松下一直是我们的最大战略供应商。
Jin Rong Jie· 2026-03-30 16:43
马斯克:特斯拉(TSLA.O)正在日本进行大规模投资,包括服务设施和超级充电站的建设。特斯拉的许 多零部件都是在日本制造的。在过去的20年里,松下一直是我们的最大战略供应商。 ...
华润万象生活2025年核心净利润达39.5亿元
Zheng Quan Ri Bao Zhi Sheng· 2026-03-30 16:43
本报记者 陈潇 "我们会继续夯实万象商业的头部地位,加大在重点城市深耕布局'一城多汇''多城多汇'。与此同时,对 于有产业支撑、经济发展好的三线城市,我们会加强研究,重点布局。"3月30日,在华润万象生活有限 公司(以下简称"华润万象生活")的业绩发布会上,公司管理层向《证券日报》记者表示,"十五五"期 间,对公司的商业板块来说是重要的战略机遇期,公司会抓住机会,加速发展。 2025年,华润万象生活交出了一份稳中有进的成绩单。年报显示,2025年公司实现营业收入180.22亿 元,同比增长5.1%;核心净利润同比增长13.7%至39.50亿元。公司连续三年实现核心净利润100%分 派,全年每股股息同比增长12.7%,盈利质量与股东回报保持在行业前列。 业绩稳健增长 华润万象生活CFO聂志章表示,"十五五"期间有信心维持每股派息长期有效增长 在资本层面,REITs政策扩容亦为行业打开新的想象空间。华润万象生活执行董事、副总裁王磊向《证 券日报》记者表示,公募REITs扩容至写字楼等资产类别,对公司而言是积极利好。 "母公司推进REITs,本质上是打通资本循环,释放资源用于再投资,这将为华润万象生活带来更多优质 ...
Bicara Therapeutics CEO Sold Over 8,000 Company Shares. Is the Stock a Sell or Buy?
Yahoo Finance· 2026-03-30 16:41
The company targets oncologists, healthcare providers, and biopharmaceutical partners focused on innovative cancer treatments for solid tumor patients.Bicara Therapeutics develops bifunctional antibody-based therapies for solid tumors, with its lead product candidate being ficerafusp alfa targeting EGFR and TGF-beta pathways.* 1-year performance is calculated using March 6, 2026 as the reference date.How does this event fit within the historical pattern of insider activity? Across seven reported transaction ...
Retirees Are Ditching Stock Picking for This 6% Income Strategy
247Wallst· 2026-03-30 16:41
Retirees Are Ditching Stock Picking for This 6% Income Strategy - 24/7 Wall St. S&P 5006,389.80 +0.43% Dow Jones45,514.80 +0.90% Nasdaq 10023,153.60 +0.21% Russell 20002,433.90 -0.39% FTSE 10010,135.00 +2.24% Nikkei 22551,434.80 -0.14% Stock Market Live March 30, 2026: S&P 500 (SPY) Up on President Trump Optimism Investing Retirees Are Ditching Stock Picking for This 6% Income Strategy By Marc GubertiPublished Mar 30, 12:41PM EDT Quick Read Options income ETFs and REITs are two of the best choices for re ...
IBRX Class Action Reminder: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ImmunityBio, Inc. Securities Fraud Class Action
Globenewswire· 2026-03-30 16:41
SAN DIEGO, March 30, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegat ...
D.R. Horton Gains on Strong Execution Amid Affordability Risks
ZACKS· 2026-03-30 16:40
Key Takeaways D.R. Horton's Q1 2026 net sales orders rose 3% to 18,300 homes, with backlog steady at $6.7B.DHI cuts cycle time by two weeks and uses 75% contract-controlled lots to boost efficiency.D.R. Horton faces margin pressure as rates hit 6.38% and Q2 margins are seen at 19%-19.5%.D.R. Horton, Inc. (DHI) is benefiting from an increase in net sales orders, demonstrating an ability to balance pace, price and incentives to drive incremental sales and maximize returns. The company’s disciplined and balanc ...